Filing Flows › Cryo Cell International (CCEL) › Q1 FY26
Cryo Cell International (CCEL) Q1 FY26 earnings results (first quarter fiscal 2026)
10-Q filed Apr 14, 2026
Cryo Cell International (CCEL) reported revenue of $7.7M for the first quarter fiscal 2026 (Q1 FY26), -4% from a year earlier and -2% from the quarter before. Operating margin was 10.0%, net earnings $47K (0.6% of revenue).
Cryo Cell International, Q1 FY26: revenue $7.7M (-4% year over year), operating margin 10.0%, net earnings $47K, operating cash flow $652K. The chart follows the revenue to costs, profit and cash.
| Q1 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.7M | -2% | -4% |
| Operating profit | $765K | — | -28% |
| Net earnings | $47K | — | -83% |
| Operating cash flow | $652K | -49% | -32% |
| Free cash flow | $585K | -52% | -34% |
What changed
Revenue was $7.7M in Q1 FY26, down 4% year over year and down 2% from the previous quarter. Processing and Storage Fees was the largest line at 99% of revenue. Processing and Storage Fees lost $223K year over year (down 3%), 78% of the total change.
Operating profit was $765K, a 10.0% margin (down 3.3 points year over year). Total costs grew 0% against a revenue fall of 4%. Net earnings were $47K, down 83% year over year. The effective tax rate was 33.0%.
Operating cash flow was $652K (down 32% year over year), 1384% of net earnings. Non-cash charges added back $244K of depreciation and amortization and $159K of share-based compensation. Working capital and other items added $202K. Capital expenditures of $67K left free cash flow of $585K.
Questions
What was Cryo Cell International's revenue in the first quarter fiscal 2026?
Cryo Cell International (CCEL) reported revenue of $7.7M for the first quarter fiscal 2026 (Q1 FY26), -4% from a year earlier and -2% from the quarter before.
Was Cryo Cell International profitable in the first quarter fiscal 2026?
Operating profit was $765K (10.0% of revenue) and net earnings $47K.